- Home
- SYNA vs LGND Comparison
SYNA vs LGND Comparison
Compare SYNA & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYNA
- LGND
- Stock Information
- Founded
- SYNA 1986
- LGND 1987
- Country
- SYNA United States
- LGND United States
- Employees
- SYNA N/A
- LGND 68
- Industry
- SYNA Computer peripheral equipment
- LGND Biotechnology: Pharmaceutical Preparations
- Sector
- SYNA Technology
- LGND Health Care
- Exchange
- SYNA Nasdaq
- LGND Nasdaq
- Market Cap
- SYNA 2.7B
- LGND 3.2B
- IPO Year
- SYNA 2002
- LGND 1992
- Fundamental
- Price
- SYNA $58.86
- LGND $202.20
- Analyst Decision
- SYNA Strong Buy
- LGND Strong Buy
- Analyst Count
- SYNA 7
- LGND 8
- Target Price
- SYNA $89.71
- LGND $144.71
- AVG Volume (30 Days)
- SYNA 434.4K
- LGND 139.7K
- Earning Date
- SYNA 11-06-2025
- LGND 08-05-2025
- Dividend Yield
- SYNA N/A
- LGND N/A
- EPS Growth
- SYNA N/A
- LGND N/A
- EPS
- SYNA N/A
- LGND N/A
- Revenue
- SYNA $1,109,100,000.00
- LGND $181,488,000.00
- Revenue This Year
- SYNA $11.05
- LGND $18.41
- Revenue Next Year
- SYNA $11.32
- LGND $18.87
- P/E Ratio
- SYNA N/A
- LGND N/A
- Revenue Growth
- SYNA 13.24
- LGND 53.40
- 52 Week Low
- SYNA $41.80
- LGND $81.74
- 52 Week High
- SYNA $89.81
- LGND $129.90
- Technical
- Relative Strength Index (RSI)
- SYNA 30.37
- LGND 56.45
- Support Level
- SYNA $62.24
- LGND $199.00
- Resistance Level
- SYNA $69.90
- LGND $208.82
- Average True Range (ATR)
- SYNA 2.59
- LGND 8.60
- MACD
- SYNA -1.09
- LGND -0.49
- Stochastic Oscillator
- SYNA 0.62
- LGND 58.47
About SYNA Synaptics Incorporated $0.001 Par Value
Synaptics Inc is a producer of semiconductor solutions for the mobile, PC, and Internet of Things markets. The company develops human interface solutions that enable touch, display, fingerprint, video, audio, voice, AI, and connectivity functions for smartphones, PCs, Internet of Things products, and other electronic devices. It operates in one segment: the development, marketing, and sale of semiconductor products used in electronic devices and products. The company geographically, it derives a majority of revenue from China, and also has its presence in Taiwan, Japan, South Korea, United States and Other countries.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.